Clinical Research

A BA study allows for the evaluation of the effect of route of administration on patient and then determination of the absolute BA of the drug released from the drug product. The BA for a certain formulation indicates the percentage of the orally supplied dose that is absorbed into the systemic circulation. Absolute Bioavailability is the term used when the reference standard is an IV dosage. Relative Bioavailability is used when the reference standard is any other dose form than IV.

  • Absolute Bioavailability
  • Systemic Circulation
  • IV Dosage

Related Conference of Clinical Research

March 18-19, 2024

20th International Conference on Cancer Research

Zurich, Switzerland
April 24-25, 2024

33rd Neonatology and Primary Care Congress

Paris, France
April 30-30, 2024

14th International Conference on Womens Health and Cancer Cure

Amsterdam, Netherlands
July 25-26, 2024

20th World Summit on Blockchain Technology

Amsterdam, Netherlands
August 20-21, 2024

11th World Summit on Epilepsy and Bipolar Disorders

Montreal, Canada

Clinical Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in